ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone Basics & Questions
Stopping Testosterone Injections for Enclomiphene
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="sammmy" data-source="post: 187691" data-attributes="member: 38594"><p>I looked at Anastrozole as a good example of a drug that induces osteoporosis due to reduction of estrogen activity in the body (due to reduced estrogen production). This is a model of what could happen if enclomiphene blocks the estrogen receptors in bones i.e. reduces the estrogen activity there despite the elevated circulating estrogen.</p><p></p><p><a href="https://www.sciencedirect.com/science/article/abs/pii/S8756328207005108" target="_blank">Estrogen-dependent increase in bone turnover and bone loss in postmenopausal women with breast cancer treated with anastrozole. Prevention with bisphosphonates</a>:</p><p></p><p></p><p>So in this case, an increase of the bone markers CTX and osteocalcin is correlated with bone loss.</p></blockquote><p></p>
[QUOTE="sammmy, post: 187691, member: 38594"] I looked at Anastrozole as a good example of a drug that induces osteoporosis due to reduction of estrogen activity in the body (due to reduced estrogen production). This is a model of what could happen if enclomiphene blocks the estrogen receptors in bones i.e. reduces the estrogen activity there despite the elevated circulating estrogen. [URL='https://www.sciencedirect.com/science/article/abs/pii/S8756328207005108']Estrogen-dependent increase in bone turnover and bone loss in postmenopausal women with breast cancer treated with anastrozole. Prevention with bisphosphonates[/URL]: So in this case, an increase of the bone markers CTX and osteocalcin is correlated with bone loss. [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone Basics & Questions
Stopping Testosterone Injections for Enclomiphene
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top